What You Should Know:
- Plexision, a biotechnology company, today announced a $365k investment from the Richard King Mellon Foundation. The funds will be used to accelerate the integration of artificial intelligence (AI) and machine learning (ML) capabilities across Plexision’s suite of cell-based blood tests, significantly improving predictive accuracy for complex transplant outcomes.
Despite advances in transplant medicine, managing immunosuppressive drugs remains a delicate
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Aidoc Secures $150M to Accelerate CARE™ Foundation Model and Clinical AI Deployment
What You Should Know:
- Aidoc, a clinical AI platform with the highest number of FDA-cleared solutions in its category, secures $150M in funding, led by General Catalyst and Square Peg, with participation from NVentures (NVIDIA's venture capital arm) and four major U.S. health systems (Hartford HealthCare, Mercy, Sutter Health, and WellSpan Health). The funding also includes a $40M revolving credit facility, bringing Aidoc's total funding to $370M.
- The $150M will be used to
Read More
Charta Health Secures $22M to Automate Medical Billing and Clinical Documentation with AI
What You Should Know:
- Charta Health, an AI-powered platform that automates and optimizes medical billing and clinical documentation workflows secures $22M in Series A funding round led by Bain Capital Ventures, with participation from Madrona, SV Angel, Refract Ventures, and South Park Commons.
- The U.S. healthcare system loses over $300 billion each year due to billing errors, undercoding, and preventable claim denials. This significant financial drain often stems from slow,
Read More
OpenEvidence Secures $210M, Launches Free AI Agent for Clinicians
What You Should Know:
- OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians raises $210M in Series B funding round, valuing the company at $3.5 billion. The round was co-led by Google Ventures and Kleiner Perkins, with follow-on investment from Series A leader Sequoia Capital, and additional participation from Coatue, Conviction, and Thrive. OpenEvidence has now raised over $300M since its founding.
- OpenEvidence is rapidly
Read More
American Heart Association Ventures™ Invests in Auxira Health to Transform Cardiology Care
What You Should Know:
- Auxira Health, a virtual cardiology platform announced a strategic collaboration with and investment from American Heart Association Ventures™, the venture capital arm of the American Heart Association®. Both organizations share a commitment to improving patient outcomes by better aligning incentives between providers and patients.
- Auxira, initially co-developed by MedStar Health and Abundant Venture Partners, launched earlier this year to address the
Read More
evolvedMD Secures $34M to Expand Integrated Behavioral Health Care Nationwide
What You Should Know:
- evolvedMD, a Collaborative Care Management (CoCM) provider, announced the close of its $34M Series B investment round, led by Sustainable Investing at Goldman Sachs Alternatives. Existing investors Conductive Ventures, FCA Venture Partners, Healthworx Ventures, Tectonic Ventures, and Waterline Ventures also participated in the round.
- The funding will be used to accelerate evolvedMD's mission to increase behavioral health care availability and expand
Read More
Asepha Secures $4M Seed for AI-Powered Pharmacy Operations
What You Should Know:
- Asepha, a fast-growing startup leveraging AI agents for pharmacy automation, today announced the close of its $4 million Seed round, led by Glasswing Ventures and Core Innovation Capital.
- Panache, RedBud, and MGV also participated, with follow-on support from Ripple Ventures and Front Row Ventures.
Asepha Raises the Bar on AI-Driven Pharmacy Automation, Expands Nationwide Footprint
Asepha is redefining pharmacy operations with
Read More
Centivax Raises $45M to Commercialize First Universal Flu Vaccine
What You Should Know:
- Centivax, a biotech company developing durable, universal vaccines, today announced the close of a $45 million Series A led by Steve Jurvetson’s Future Ventures, with participation from NFX, BOLD Capital, Base4, Kendall Capital Partners, Amplify Bio, and existing investors.
- The new funding will advance Centivax’s lead universal flu vaccine candidate through CMC development and into a Phase I trial within eight months.
Centivax Accelerates Universal Vaccine
Read More
Plexāā Closes $4.5M Extension to Bring Wearable Device for Breast Cancer Surgery to U.S.
What You Should Know:
- Plexāā, a pioneering UK-based MedTech startup behind the award-winning BLOOM⁴³ medical device for breast surgery closes $4.5M funding extension round led by TCP Health Ventures. The extension round includes both existing and new investors, including TCP. Further investment comprises over $1.6M in i4i grant funding from the National Institute for Health and Care Research (NIHR), and $1.3M from Thena Capital, a London-based VC firm backed by the British Business
Read More
Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025
What You Should Know:
- The first half of 2025 saw a modest increase in digital health venture funding, reaching $6.4B across 245 deals for US-based digital health companies, according to Rock Health’s latest report on H1 2025 digital health trends.
- The numbers is up from $6B in H1 2024 and $6.2B in H1 2023, signaling a steady venture market that has found its footing post-pandemic. Q2 alone brought in $3.4B, exceeding the average of $2.6B per quarter since Q1 2023.
AI
Read More
